Dashboard
Manage Tickers

IVVD Invivyd, Inc.

Nasdaq invivyd.com


$ 1.69 $ -0.25 (-13.3 %)    

Tuesday, 14-Oct-2025 19:20:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 1.63
$ 1.78
$ 1.60 x 2,000
$ 1.79 x 400
$ 1.56 - $ 1.84
$ 0.35 - $ 2.74
9,241,545
na
195.83M
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 09-20-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

d-boral-capital-maintains-buy-on-invivyd-raises-price-target-to-2
D. Boral Capital Maintains Buy on Invivyd,...
10/06/2025 18:03:17

D. Boral Capital analyst Jason Kolbert maintains Invivyd (NASDAQ:IVVD) with a Buy and raises the price target from $1 to $2.

this-commerce-bancshares-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This Commerce Bancshares Analyst Begins Co...
10/06/2025 12:53:04

5-analysts-have-this-to-say-about-invivyd
5 Analysts Have This To Say About Invivyd
10/06/2025 12:02:22

the-fda-clears-invivyds-investigational-new-drug-application-and-provided-feedback-to-advance-its-revolution--clinical-development-program-for-vyd2311-a-vaccine-alternative-monoclonal-antibody-candidate-to-prevent-covid-infection
The FDA Clears Invivyd's Investigational N...
10/06/2025 11:12:28

The DECLARATION clinical trial is the company's Biologics License Application (BLA)-enabling, Phase 3 pivotal clinical tria...

cantor-fitzgerald-initiates-coverage-on-invivyd-with-overweight-rating-announces-price-target-of-10
Cantor Fitzgerald Initiates Coverage On In...
10/06/2025 11:09:37

Cantor Fitzgerald analyst Josh Schimmer initiates coverage on Invivyd (NASDAQ:IVVD) with a Overweight rating and announces P...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/03/2025 12:08:34

invivyd-filed-for-350m-mixed-shelf-offering
Invivyd Filed For $350M Mixed Shelf Offering
10/02/2025 20:15:25

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/10/2025 17:07:06

steven-cohens-biotech-bets-are-getting-bolder--and-smaller
Steven Cohen's Biotech Bets Are Getting Bo...
08/29/2025 16:42:51

Billionaire hedge fund manager Steven Cohen is diving into small-cap biotech with new stakes in two clinical-stage companies, s...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/27/2025 21:06:08

point72-hedge-fund-manager-steve-cohen-discloses-8-passive-stake-in-invivyd
Point72 Hedge-Fund Manager, Steve Cohen, D...
08/27/2025 20:58:48

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/27/2025 17:06:12

hc-wainwright--co-reiterates-buy-on-invivyd-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Invi...
08/27/2025 10:49:56

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Invivyd (NASDAQ:IVVD) with a Buy and maintains $5 price target.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/26/2025 17:06:55

us-stocks-mixed-american-woodmark-posts-downbeat-sales
US Stocks Mixed; American Woodmark Posts D...
08/26/2025 13:55:28

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/26/2025 12:09:56

why-serina-therapeutics-shares-are-trading-higher-by-over-25-here-are-20-stocks-moving-premarket
Why Serina Therapeutics Shares Are Trading...
08/26/2025 09:52:07

d-boral-capital-maintains-buy-on-invivyd-lowers-price-target-to-1
D. Boral Capital Maintains Buy on Invivyd,...
08/25/2025 12:21:53

D. Boral Capital analyst Jason Kolbert maintains Invivyd (NASDAQ:IVVD) with a Buy and lowers the price target from $3 to $1.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/21/2025 17:05:56

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/21/2025 12:08:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION